B-cell lymphoma vaccine (BiovaxID) for follicular non-Hodgkin's lymphoma (Structured abstract)      
B-type natriuretic peptide assays in the diagnosis of heart failure. Part A: in the hospital emergency setting. Part B: in the non-hospital setting (Structured abstract)      
B-type natriuretic peptide (BNP) for the diagnosis and management of congestive heart failure (Structured abstract)      
B-type natriuretic peptide for diagnosing congestive heart failure (Structured abstract)      
B-type natriuretic peptide for diagnosing heart failure (Structured abstract)      
B-type natriuretic peptide - incorporating application 1086 (1087) (Project record)      
B-type natriuretic peptide - incorporating application (Project record)      
B-type natriuretic peptide (Structured abstract)      
B-type natriuretic peptide testing: a rapid review (Structured abstract)      
B vitamins and berries and age-related neurodegenerative disorders (Structured abstract)      
Baby sighted! Conspicuous ultrasound findings and their consequences (Short version of the TA study 'Ultrasound diagnostic during pregnancy') (Structured abstract)      
Bach flower remedies for pain relief and psychological problems. Systematic review (Structured abstract)      
Back and neck pain (Structured abstract)      
Back pain - a health technology assessment (Project record)      
Back pain - causes, diagnosis, treatment (Structured abstract)      
Back pain. Diagnosis and treatment according to evidence-based guidelines - options and limitations (Structured abstract)      
Background paper one. Methods used in the measurement of bone density (INAHTA Joint Project) (Structured abstract)      
Background paper three. A review of the evidence of hormone replacement therapy and calcitonin in reducing bone loss and fractures (INAHTA Joint Project) (Structured abstract)      
Background paper two. Predictive value of bone densitometry (INAHTA Joint Project) (Structured abstract)      
BacLite MRSA detection test for methicillin-resistant Staphylococcus aureus (MRSA) colonisation - horizon scanning review (Structured abstract)      
Bacterial meningitis and meningococcal septicaemia in children (Structured abstract)      
BAHA devices in hypoacusia (Structured abstract)      
BAHA® bone-anchored hearing aid for the treatment of hearing loss (Structured abstract)      New 
Balance Right in Multiple Sclerosis (BRiMS): a guided self-management programme to reduce falls and improve quality of life, balance and mobility in people with Multiple Sclerosis (Project record)      New 
Balloon angioplasty of pulmonary vein stenosis in infants (Structured abstract)      
Balloon angioplasty with or without stenting for coarctation or recoarctation of the aorta in adults and children (Structured abstract)      
Balloon dilatation of pulmonary valve stenosis (Structured abstract)      
Balloon dilatation of systemic to pulmonary arterial shunts in children (Structured abstract)      
Balloon dilatation with or without stenting for pulmonary artery or non-valvar right ventricular outflow tract obstruction in children (Structured abstract)      
Balloon Eustachian tuboplasty for the treatment of Eustachian tube dysfunction - German short version and update of the correspondent EUnetHTA assessment (Structured abstract)      
Balloon gastrostomy devices for adults: guidelines for replacement, maintenance, and training (Structured abstract)      
Balloon gastrostomy devices for adults: guidelines for replacement, maintenance, and training (Structured abstract)      
Balloon kyphoplasty: an evidence-based analysis (Structured abstract)      
Balloon kyphoplasty for treatment of painful osteoporotic vertebral compression fractures : an evidence update (Structured abstract)      
Balloon kyphoplasty for vertebral compression fractures (Structured abstract)      
Balloon kyphoplasty for vertebral compression fractures (Structured abstract)      
Balloon sinuplasty for chronic rhinosinusitis (Structured abstract)      
Balloon sinus ostial dilation for treatment of chronic rhinosinusitis (Structured abstract)      
Balloon tamponade for postpartum hemorrhage (Structured abstract)      
Balloon thermal endometrial ablation (Structured abstract)      
Balloon valvuloplasty for aortic valve stenosis in adults and children (Structured abstract)      
Balneophototherapy for treatment of psoriasis (Structured abstract)      
BaP and PAH from coal-derived sources: health-based calculated occupational cancer risk values of benzo[a]pyrene and unsubstituted non-heterocyclic polycyclic aromatic hydrocarbons from coal-derived sources (Structured abstract)      
Barcoding of medical items and patients to increase patient safety (Structured abstract)      
Bard(R) endoscopic suturing system (Structured abstract)      
Bariatric surgery: an evidence-based analysis (Structured abstract)      
Bariatric surgery and nonsurgical therapy in adults with metabolic conditions and a body mass index of 30.0 to 34.9 kg/m2 (Structured abstract)      
Bariatric surgery for obese patients with co-morbidities: a review of clinical effectiveness, cost-effectiveness, and guidelines (Structured abstract)      
Bariatric surgery for people with diabetes and morbid obesity: an evidence-based analysis (Structured abstract)      
Bariatric surgery for severe obesity: systematic review and economic evaluation (Structured abstract)      
Bariatric surgery for the treatment of morbid obesity - systematic review (Structured abstract)      
Bariatric surgery in adolescents with severe obesity (Structured abstract)      
Bariatric surgery in adults (Structured abstract)      
Bariatric surgery in diabetic type 2 patients with CMI at or above 30 kg/m2 (Structured abstract)      
Bariatric surgery in patients with diabetes and body mass index less than 35 kg/m2 (Structured abstract)      
Bariatric surgery in women of reproductive age: special concerns for pregnancy (Structured abstract)      
Bariatric surgery (Project record)      
Bariatric surgery (Structured abstract)      
Bariatric surgery (Structured abstract)      
Bariatric surgical procedures for obese and morbidly obese patients: a review of comparative clinical and cost-effectiveness, and guidelines (Structured abstract)      
Bariatric treatments for adult obesity (Structured abstract)      
Baricitinib for moderate to severe rheumatoid arthritis (Structured abstract)      
Baropodometric gait analysis (Structured abstract)      
Barriers and drivers of health IT use for the elderly, chronically ill, and underserved (Structured abstract)      
Barriers and facilitators to smoking cessation in pregnancy and following childbirth (Project record)      
Barriers and opportunities for the uptake of biosimilar medicines in Belgium (Structured abstract)      
Barriers to community care (Structured abstract)      
BARRX's HALO360 coagulation system (BARRX Medical Inc.) for Barrett's esophagus (Structured abstract)      
BATHE (Bath Emollients for Treatment of cHildhood Eczema) (Project record)      
Battery replacement and maintenance of deep brain stimulators: guidelines and recommendations (Structured abstract)      
Bavituximab for advanced non-small cell lung cancer ? second line in combination with docetaxel (Structured abstract)      
Bayesian meta-analysis method (Structured abstract)      
Bayesian methods in health technology assessment: a review (Structured abstract)      
Bayley scales of infant (and toddler) development testing (Pearson Education Inc.) for developmental delays in infants (Structured abstract)      
BCR-ABL testing in chronic myelogenous leukemia (CML) (Structured abstract)      
BD veritor system for rapid detection of flu A+B (Becton, Dickinson and Company) for detection of Influenza types A and B viral antigens (Structured abstract)      
Beam and isotope radiotherapy (Structured abstract)      
BEAT-IT: A randomised controlled trial comparing a behavioural activation treatment for depression in adults with learning disabilities with an attention control (Project record)      
BEC-2 for small cell lung cancer - horizon scanning review (Structured abstract)      
Beclometasone dipropionate/formoterol fumarate (Fostair®) (Structured abstract)      
Bed sharing, pacifier, breastfeeding and cot-death - is there an association? (Structured abstract)      
Bedaquiline (Sirturo®) (Structured abstract)      
Beds and mattresses designed to prevent pressure ulcers (Structured abstract)      
Begelomab (Begesand) - graft versus host disease: acute; steroid resistant ? second line (Project record)      New 
Behavioral and physical treatments for migraine headache (Structured abstract)      
Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the U.S. Preventive Services Task Force (Structured abstract)      
Behavioral counseling in primary care to promote physical activity: recommendations and rationale (Structured abstract)      
Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use (Structured abstract)      
Behavioral counseling to prevent sexually transmitted infections (Structured abstract)      
Behavioral counseling to prevent skin cancer: systematic evidence review to update the 2003 U.S. Preventive Services Task Force Recommendation (Structured abstract)      
Behavioral counseling to promote a healthy lifestyle for cardiovascular disease prevention in persons with cardiovascular risk factors: an evidence update for the U.S. Preventive Services Task Force (Structured abstract)      
Behavioral interventions and counseling to prevent child abuse and neglect: systematic review to update the U.S. Preventive Services Task Force Recommendation (Structured abstract)      
Behavioral programs for diabetes mellitus (Structured abstract)      
Behavioral sexual risk reduction counseling in primary care to prevent sexually transmitted infections: an updated systematic evidence review for the U.S. Preventive Services Task Force (Structured abstract)      
Behavioral therapy programs for weight loss in adults (Structured abstract)      
Behaviour change techniques: the development and evaluation of a taxonomic method for reporting and describing behaviour change interventions (a suite of five studies involving consensus methods, randomised controlled trials and analysis of qualitative data) (Structured abstract)      
Behaviour therapy for obesity treatment considering approved drug therapy (Structured abstract)      
Behavioural Activation Therapy for Depression after Stroke (BEADS): a feasibility randomised controlled pilot trial of a psychological intervention for post-stroke depression (Project record)      
Behavioural and skill-based early interventions in children with autism spectrum disorders (Structured abstract)      
Behavioural interventions for preschool children with autism (Structured abstract)      
Behavioural interventions for type 2 diabetes: an evidence-based analysis (Structured abstract)      
Behavioural interventions for urinary incontinence in community-dwelling seniors: an evidence-based analysis (Structured abstract)      
Behavioural interventions to reduce the risk of sexually transmitted infections in genitourinary medicine clinic patients: a systematic review (Structured abstract)      
Being a manager, becoming a professional? A case study and interview-based exploration of the use of management knowledge across communities of practice in health-care organisations (Structured abstract)      
Belatacept: addendum to Commission A15-25 (Structured abstract)      
Belatacept: benefit assessment according to § 35a Social Code Book V (dossier assessment) (Structured abstract)      
Belatacept -Benefit assessment according to § 35a Social Code Book V (dossier assessment) (Structured abstract)      
Belatacept for prophylaxis of organ rejection in renal transplantation (Structured abstract)      
Belatacept (Nulojix®) (Structured abstract)      
Belgian guidelines for economic evaluations and budget impact analyses: second edition (Structured abstract)      
Belimumab - Benefit assessment according to § 35a Social Code Book V (dossier assessment) (Structured abstract)      
Belimumab (Benlysta) for active systemic lupus erythematosus (Structured abstract)      
Belimumab for the treatment of active autoantibody-positive systemic lupus erythematosus (Project record)      
Belimumab for the treatment of systemic lupus erythematosus (Project record)      
Belimumab for the treatment of Systemic Lupus Erythematosus (Structured abstract)      
Bendamustine for chronic lymphocytic leukaemia (Project record)      
Bendamustine for the treatment of chronic lymphocytic leukaemia (Structured abstract)      
Bendamustine for the treatment of follicular lymphoma (Structured abstract)      
Bendamustine for the treatment of indolent (low grade) non-Hodgkin's lymphoma that is refractory to rituximab (terminated appraisal) (Structured abstract)      
Bendamustine in combination with rituximab for the first-line treatment of indolent non-Hodgkin's lymphoma (Project record)      
Bendamustine (Ribomustin/Treanda/ Levact) for indolent non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukaemia (CLL) and multiple myeloma (Structured abstract)      
Benefit assessment of an HPV test in primary screening for cervical cancer: rapid report (Structured abstract)      
Benefit assessment of HPV test in primary screening for cervical cancer (Structured abstract)      
Benefit assessment of long-term blood glucose lowering to normal levels in patients with diabetes mellitus type 2 - Rapid report (Structured abstract)      
Benefit assessment of long-term lowering of blood pressure to levels in the lower normal range in patients with diabetes mellitus - rapid report (Structured abstract)      
Benefit assessment of non-drug treatment strategies in patients with diabetes mellitus type 2: increase of physical activity - rapid report (Structured abstract)      
Benefit assessment of non-drug treatment strategies in patients with essential hypertension: special diets without the primary aim of reducing weight or salt intake - rapid report (Structured abstract)      
Benefit design in health care reform: patient cost-sharing (Structured abstract)      
The benefit of HLA-matching in kidney transplantation (Structured abstract)      
Benefit of homologous bone marrow transplantation in patients with lymphoma - primary research (Structured abstract)      
The benefit of moving antenatal classes out of the hospital into the community (Structured abstract)      
Benefit of phrenic nerve stimulation for patients with complete traumatic lesion of the spinal cord and loss of spontaneous breathing (Structured abstract)      
The benefit of population screening for breast cancer with mammography - Systematic review, expert panel (Structured abstract)      
The benefit of surgery of arm fractures in elderly (Project record)      
Benefits and harms of prostate-specific cancer screening: an evidence update for the U.S. Preventive Services Task Force (Structured abstract)      
Benefits and harms of routine preoperative testing: comparative effectiveness (Structured abstract)      
Benefits and risks of fortifying flour with folic acid to reduce the risk of neural tube defects (Structured abstract)      
Benefits and risks of hormonal contraception for women (Structured abstract)      
Benefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) Trial (Project record)      
Benefits of Incentives for Breastfeeding and Smoking cessation in pregnancy (BIBS): a mixed-methods study to inform trial design (Structured abstract)      
Benefits of recombinant thyroid stimulating hormone (rhTSH) in thyroid cancer follow-up (Structured abstract)      
Benign prostatic hyperplasia: diagnostic and treatment (Structured abstract)      
Benign prostatic hyperplasia (Structured abstract)      
Benign prostatic hyperplasia (Structured abstract)      
Benign prostatic hyperplasia treatments (Structured abstract)      
Benign Prostatic Obstruction (BPO) (Structured abstract)      
The Benozzi® method (pilocarpine eye drops) for the treatment of presbyopia (Structured abstract)      
Benralizumab for uncontrolled asthma ? second line (Structured abstract)      
Benzocaine-associated methemoglobinemia in dental patients (Structured abstract)      
Benzodiazepines for the treatment of post traumatic stress disorder: a review of the clinical effectiveness and guidelines (Structured abstract)      
Benzodiazepines in older adults: a review of clinical effectiveness, cost-effectiveness, and guidelines (Structured abstract)      
Benzodiazepines in the treatment of alcohol dependence (Project record)      
Bernese periacetabular osteotomy for developmental dysplasia of the hip (Structured abstract)      
Best-case series for the use of immuno-augmentation therapy and naltrexone for the treatment of cancer (Structured abstract)      
Best Practice in undertaking and reporting HTA. Working Group 4 Final Report (Structured abstract)      
Best practices for preventing aspiration pneumonia in hospitalized patients (Structured abstract)      
Best practices in the management of behavioural and psychological symptoms of dementia in residents of long-term care facilities in Alberta (Structured abstract)      
The Best Services Trial (BeST?): Effectiveness and cost-effectiveness of the New Orleans Intervention Model for Infant Mental Health (Project record)      
Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome (Structured abstract)      
Beta amyloid imaging with Positron Emission Tomography (PET) for evaluation of suspected alzheimer's disease or other causes of cognitive decline (Structured abstract)      
Beta human chorionic gonadotropin test for detection of early pregnancy: clinical effectiveness, cost-effectiveness, and guidelines (Structured abstract)      
Beta intererons (1a and 1b) in elapsing-remitting and secondary progressive multiple sclerosis (Structured abstract)      
Beta-interferon treatment in RRMS and secondary progressive multiple sclerosis (Structured abstract)      
Beta-tricalcium phosphate bone void filler (Structured abstract)      
Betagalsidade for Fabry disease (Project record)      
Betrixaban for the prevention of venous thromboembolism ? first line (Structured abstract)      
Between hope and despair: ALS patients and riluzole (Structured abstract)      
Between the pantry and the pharmacy: functional food - a grey area. Short version of the TA-study 'functional food' (Structured abstract)      
Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer (Structured abstract)      
Bevacizumab (avastin) for advanced and metastatic breast cancer (stages III and IV): horizon scanning review (Structured abstract)      
Bevacizumab (Avastin) for advanced metastatic ovarian cancer (Structured abstract)      
Bevacizumab (avastin) for advanced renal cell carcinoma: horizon scanning review (Structured abstract)      
Bevacizumab (Avastin) for age-related macular degeneration (Structured abstract)      
Bevacizumab (Avastin) for breast cancer - metastatic, first line (in combination with non-taxanes): horizon scanning technology briefing (Structured abstract)      
Bevacizumab (Avastin) for colorectal cancer (Structured abstract)      
Bevacizumab (Avastin) for first-line treatment of metastatic colorectal cancer - horizon scanning review (Structured abstract)      
Bevacizumab (Avastin) for glioblastoma multiforme - relapsed (Structured abstract)      
Bevacizumab (Avastin) for metastatic gastric cancer - first line in combination with capecitabine and cisplatin (Structured abstract)      
Bevacizumab (Avastin) for newly diagnosed glioblastoma multiforme ? first line (Structured abstract)      
Bevacizumab (Avastin) for non-small cell lung cancer (nsclc) - horizon scanning review (Structured abstract)      
Bevacizumab (Avastin) for non-small cell lung cancer (Structured abstract)      
Bevacizumab (Avastin) for pancreatic cancer - first line metastatic: horizon scanning technology briefing (Project record)      
Bevacizumab (Avastin) for recurrent or persistent stage IVB cervical cancer ? in combination with chemotherapy (Structured abstract)      
Bevacizumab (Avastin) for relapsed platinum-resistant ovarian cancer ? second line (Structured abstract)      
Bevacizumab (Avastin) for triple negative adjuvant breast cancer; in combination with taxane and/or anthracycline chemotherapy (Structured abstract)      
Bevacizumab (Avastin) for triple negative adjuvant breast cancer; in combination with taxane and/or anthracycline chemotherapy (Structured abstract)      
Bevacizumab (Avastin) in combination with docetaxel for metastatic breast cancer - first line (Structured abstract)      
Bevacizumab (Avastin) in combination with trastuzumab and chemotherapy for HER2-positive, node-positive or high risk node-negative breast cancer ? adjuvant therapy (Structured abstract)      
Bevacizumab (Avastin) in combination with trastuzumab and docetaxel for metastatic HER2 positive breast cancer - first line (Structured abstract)      
Bevacizumab (Avastin) with erlotinib (Tarceva) for EGFR positive, advanced or metastatic non-small cell lung cancer ? first line (Structured abstract)      
Bevacizumab (Avastin) with lomustine for glioblastoma ? second line (Structured abstract)      
Bevacizumab (Avastin) with octreotide (Sandostatin) for high risk carcinoid tumours ? first or second line (Structured abstract)      
Bevacizumab (Avastin®) as maintenance therapy after first progression on bevacizumab for patients with advanced colorectal cancer (Structured abstract)      
Bevacizumab (Avastin®) for non-small cell lung cancer (Structured abstract)      
Bevacizumab (Avastin®) for platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer (Structured abstract)      
Bevacizumab (Avastin®) in addition to standard chemotherapy for the first-line treatment of ovarian cancer (Structured abstract)      New 
Bevacizumab (Avastin®) in combination with chemotherapy as second-line therapy for HER2-negative, locally recurrent or metastatic breast cancer that has progressed after first-line treatment with bevacizumab plus chemotherapy (Structured abstract)      
Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma (Structured abstract)      
Bevacizumab for advanced colorectal cancer (Structured abstract)      
Bevacizumab for previously treated, human epidermal growth factor receptor2-negative metastatic breast cancer (Structured abstract)      
Bevacizumab for the first-line treatment of metastatic breast cancer (replaced by TA214) (Structured abstract)      
Bevacizumab for the treatment of non-small-cell lung cancer (Structured abstract)      
Bevacizumab for the treatment of patients with advanced colorectal cancer (Structured abstract)      
Bevacizumab in combination with a taxane for the first-line treatment of HER2-negative metastatic breast cancer (Structured abstract)      
Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer (Structured abstract)      
Bevacizumab in combination with capecitabine for 1st line treatment of metastatic breast cancer (Project record)      
Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first-line treatment of metastatic colorectal cancer (Structured abstract)      
Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancer (Structured abstract)      
Bevacizumab in the treatment of advanced colon cancer- review (Structured abstract)      
Bevacizumab, sorafenib tosylate and sunitinib for renal cell carcinoma: a systematic review and economic evaluation (Structured abstract)      
Bexarotene for cutaneous T-cell lymphoma - horizon scanning review (Structured abstract)      
Bexarotene (Targretin) (Structured abstract)      
Bexxar for non-Hodgkin's lymphoma (Structured abstract)      
Bexxar (tositumomab and iodine-131 tositumomab) (GlaxoSmithKline) for treatment of refractory or relapsed non-Hodgkin's lymphoma (NHL) (Structured abstract)      
Bezlotoxumab for treatment and prevention of recurrence of Clostridium difficile infection (Structured abstract)      
BG-12 for moderate to severe psoriasis - horizon scanning review (Structured abstract)      
BHR-100 for severe traumatic brain injury ? first line (Structured abstract)      
BI 201335 for chronic hepatitis C infection (Structured abstract)      
Biabsorbable versus metalic screws for anterior cruciate ligament reconstruction (Structured abstract)      
BIBF 1120 for advanced and/or metastatic non-small cell lung cancer - second line (Structured abstract)      
Bibliographic impact of reports and scientific papers written by the Spanish health technology assessment agencies and units (Project record)      
Bibliographic impact of reports and scientific papers written by the Spanish health technology assessment agencies and units (Project record)      
Bibliography on systematic reviews: locating, understanding and using the evidence (Structured abstract)      
BIBW 2992 (Tovok) for advanced or metastatic non-small cell lung cancer after failure of at least one reversible EGFR inhibitor (Structured abstract)      
Bifocal lenses under +0.50 diopter: a review of the clinical effectiveness and guidelines (Structured abstract)      
BIIB-017 for relapsing forms of multiple sclerosis (Structured abstract)      
Bilateral cochlear implantation (CI) in children: early assessment briefs (Alert) (Structured abstract)      
Bilateral cochlear implantation in adults (Structured abstract)      
Bilateral cochlear implantation in children (Structured abstract)      
Bilateral cochlear implants in children: effectiveness, safety and cost. Situation in the Spanish regions (Structured abstract)      
Bilateral DBS of the subthalamic nucleus or the globus pallidus interna for treatment of advanced Parkinson's disease (Structured abstract)      
Bilevel positive airway pressure for the treatment of obstructive sleep apnea in adults (Structured abstract)      
Biliary drainage for chemotherapy patients (Structured abstract)      
Bimagrumab for sporadic inclusion body myositis ? first line (Structured abstract)      
Binaural inner ear implants (Project record)      
Binimetinib for recurrent or persistent ovarian, fallopian tube or primary peritoneal cancer ? second and subsequent line (Structured abstract)      
Bioabsorbable everolimus-eluting coronary stent (BVS) for treatment of coronary artery disease (Structured abstract)      
Bioabsorbable stents for adults with coronary artery disease: a review of the clinical effectiveness, cost-effectiveness, and guidelines (Structured abstract)      
Bioabsorbable stents for coronary artery disease (Structured abstract)      
Biochemical markers for bone turnover in osteoporosis (Structured abstract)      
Biochemical markers of cardiovascular disease risk (Structured abstract)      
Biochemical screening for fetal chromosomal abnormalities and neural tube defects - a technology assessment (Structured abstract)      
Biochemical screening for fetal chromosomal abnormalities and neural tube defects - a technology assessment (Structured abstract)      
Biodegradable stents for the treatment of refractory or recurrent benign oesophageal stenoses (Structured abstract)      
Bioelectric impedance in assessing body weight during hemodialysis (Project record)      
Bioengineered skin and dermal cell replacement for chronic diabetic ulcers (Structured abstract)      
Bioengineered skin substitutes for the management of burns: a systematic review (Structured abstract)      
Bioengineered skin substitutes for the management of wounds: a systematic review (Structured abstract)      
Biofeedback as an adjunct to physical therapy for recovery after stroke (Structured abstract)      
Biofeedback for headache and chronic musculoskeletal pain (Structured abstract)      
Biofeedback for the treatment of constipation in children (Structured abstract)      
Biofeedback for the treatment of dysfunctional voiding in children (Structured abstract)      
Biofeedback for the treatment of fecal incontinence (Structured abstract)      
Biofeedback for the treatment of hypertension (Structured abstract)      
Biofeedback for women with urinary, fecal or combined incontinence (Structured abstract)      
Biofeedback therapy for vulvodynia (Structured abstract)      
Bioidentical hormone replacement therapy for menopausal symptoms (Structured abstract)      
Bioimpedance for assessment of lymphedema (Structured abstract)      
BioImpedance Spectroscopy To maintain Renal Output: the BISTRO trial (Project record)      New 
Bioimpedance vector analysis in the assessment of nutritional status and body fluid volume in patients with chronic renal failure (Structured abstract)      
Biologic agents for psoriasis (Structured abstract)      
Biologic agents for the treatment of psoriasis (Structured abstract)      
Biologic and nonbiologic systemic agents and phototherapy for treatment of chronic plaque psoriasis (Structured abstract)      
Biologic medications as second-line therapy for rheumatoid arthritis (Structured abstract)      
Biologic response modifier agents as first-line treatment for patients with rheumatoid arthritis: a review of the clinical efficacy, cost-effectiveness and guidelines (Structured abstract)      
Biologic response modifier agents for adults with rheumatoid arthritis (Structured abstract)      
Biological indicators for sterilization of medical devices in primary care (Structured abstract)      
Biological mesh for abdominal hernia repair (Structured abstract)      
Biological therapies in the treatment of anaemia associated with chronic kidney disease: a comparison of efficacy and safety of different erythropoiesis-stimulating agents (Structured abstract)      
Biological therapies in the treatment of ankylosing spondylitis: a comparison of efficacy and safety between different biological inhibitors of tumour necrosis factor-alpha (Structured abstract)      
Biological therapies in the treatment of rheumatoid arthritis (Structured abstract)      
Biological tissue adhesive versus standard suture in conjuctival autograft for the surgical treatment of pterygium (Structured abstract)      
Biological tissue-engineered skin substitutes for wound healing (Structured abstract)      
Biologicals in patients with psoriasis, infliximab (REMICADE) therapy (Structured abstract)      
Biologicals in patients with spondylitis ankylopoetica; the (REMICADE) therapy (Structured abstract)      
Biologics for early rheumatoid arhritis (Structured abstract)      
Biology of haemostasis abnormalities ? summary (Structured abstract)      
Biology of haemostasis disorders: bleeding time (Structured abstract)      
Biology of haemostasis disorders: detection and titration of antihaemophilic factor (AHF) inhibitor (Structured abstract)      
Biology of haemostasis disorders: lupus anticoagulant detection (Structured abstract)      
Biology of haemostasis disorders: photometric platelet aggregation test (Structured abstract)      
Biology of haemostasis disorders: testing for antibodies to platelet factor 4 in a patient with heparin ? induced thrombocytopenia (Structured abstract)      
Biology of haemostasis disorders: testing for the G1691A mutation of the factor V gene (Leiden FV) and the G20210A mutation of the factor II gene (Structured abstract)      
Biology of haemostasis disorders: thrombin time (Structured abstract)      
Biomarkers for assessing and managing iron deficiency anemia in late-stage chronic kidney disease (Structured abstract)      
Biomedical treatment and diet supplements for the treatment of the autism spectrum disorder (Structured abstract)      
BioMimics 3D? stent for peripheral artery disease (Structured abstract)      
BioniCare knee device (ArthroWave Medical Technologies LLC) for osteoarthritis of the knee (Structured abstract)      
BioniCare Knee System (VQ OrthoCare) for treatment of osteoarthritis of the knee (Structured abstract)      
Biopatch antimicrobial dressing (Integra LifeSciences Corp. and Ethicon Inc., a division of Johnson & Johnson Co.) for prevention of catheter- and device-related bloodstream infections (Structured abstract)      
Bioprothesis Perceval S, sutureless aortic valve replacement (Structured abstract)      
Bioquell airborne disinfection system (Structured abstract)      
Bioresonance for allergies, atopic dermatitis, non-organic gastrointestinal complaints, pain and rheumatic diseases (Structured abstract)      
Bioresorbable stents for occlusive coronary artery disease (Structured abstract)      
Biosensors in medicine, a proactive technology assessment (Structured abstract)      
Biosynthetic tissue-engineered skin substitutes for wound healing (Structured abstract)      
Biosynthetic tissue-engineered skin substitutes for wound healing (Structured abstract)      
Bioterrorism preparedness and response: use of information technologies and decision support systems (Structured abstract)      
Biotin (Cerenday) for permanent disability related to multiple sclerosis relapses ? add on therapy to current immunomodulators (Structured abstract)      
Biotin (Cerenday) for primary and secondary progressive multiple sclerosis - first line (Structured abstract)      
Bipolar disorder: the management of bipolar disorder in adults, children and adolescents, in primary and secondary care (Structured abstract)      
Bipolar plasmakinetic electrovaporization for benign prostatic hyperplasia (BPH) (Structured abstract)      
Birmingham and Lambeth Liver Evaluation Testing Strategies (BALLETS): a prospective cohort study (Structured abstract)      
The Birmingham Rehabilitation Uptake Maximisation Study (BRUM). Home-based compared with hospital-based cardiac rehabilitation in a multi-ethnic population: cost-effectiveness and patient adherence (Structured abstract)      
The birth of a new type of treatment. Cells extracted from other species for use in treating diseases in humans. (Short version of the TA study 'Xenotransplantation of cells') (Structured abstract)      
The Birthplace in England national prospective cohort study: further analyses to enhance policy and service delivery decision-making for planned place of birth (Structured abstract)      
Bispectral index monitor: an evidence-based analysis (Structured abstract)      
Bispectral index monitoring (BIS) for measuring the depth of anaesthesia and to facilitate anaesthetic titration (Structured abstract)      
Bispectral index monitoring for anesthesia awareness (Structured abstract)      
Bisphosphonate agents for the management of pain secondary to bone metastases: a systematic review of effectiveness and safety (Structured abstract)      
Bisphosphonates (alendronate and etidronate) in the management of osteoporosis (Structured abstract)      
Bisphosphonates (alendronate, etidronate, risedronate), selective oestrogen receptor modulators (raloxifene) and parathyroid hormone (teriparatide) for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (Structured abstract)      
Bisphosphonates and teriparatide for the prevention of osteoporotic fractures in postmenopausal women (Structured abstract)      
Bisphosphonates as treatment for breast cancer (Structured abstract)      
Bisphosphonates for the prevention of osteoporosis in patients treated with systematic corticosteroids: a review of the clinical evidence and guidelines (Structured abstract)      
Bisphosphonates for the primary and secondary prevention of osteoporotic fractures in postmenopausal women: a meta-analysis (Structured abstract)      
Bisphosphonates (Structured abstract)      
Bitopertin for schizophrenia: primary, persistent negative symptoms; sub-optimally controlled positive symptoms ? in combination with antipsychotics (Structured abstract)      
Bitumen (vapour and aerosol); Health-based recommended occupational exposure limit (Structured abstract)      
Bivalirudin (Angiox) for acute myocardial infarction with persistent ST-segment elevation treated by primary percutaneous coronary intervention (Structured abstract)      
Bivalirudin (Angiox®) for the treatment of adult patients with acute coronary syndromes planned for urgent or early intervention (Structured abstract)      
Bivalirudin for percutaneous coronary intervention (PCI) (Structured abstract)      
Bivalirudin for percutaneous coronary interventions (PCI) - horizon scanning review (Structured abstract)      
Bivalirudin for the treatment of ST-segment elevation myocardial infarction (Project record)      
Bivalirudin infusion following angioplasty: safety (Structured abstract)      
Bivalirudin infusion following angioplasty: safety (Structured abstract)      
Bivalirudin (Structured abstract)      
Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis (Structured abstract)      
Biventricular pacing systems (cardiac resynchronization therapy) for heart failure (Structured abstract)      
Black cohosh for the treatment of menopausal symptoms (Structured abstract)      
Bladder cancer: an assessment of international practice guidelines (Structured abstract)      
Bladder cancer surveillance (Structured abstract)      
Bladder instillation of gentamicin for the treatment of recurrent urinary tract infections: clinical evidence and guidelines (Structured abstract)      
Bladder tumor antigen test (Structured abstract)      
Bladder ultrasonography for diagnosing detrusor overactivity: test accuracy study and economic evaluation (Structured abstract)      
Bladder ultrasound scanning for the measurement of post-void residual urine volume (Structured abstract)      
Bladderchek: diagnostic test for bladder cancer (Structured abstract)      
The bleeding patterns which can occur with long term hormone replacement therapy (HRT) and how they correlate with endometrial pathology (Structured abstract)      
Bleeding peptic ulcer (Structured abstract)      
Bleeding risks from celecoxib vs. non-selective NSAIDS in orthopedic surgery (Structured abstract)      
Blinatumomab - assessment according to §35a (para. 1, sentence 10) Social Code Book V (Structured abstract)      
Blinatumomab (Blincyto) for B-precursor acute lymphoblastic leukaemia minimal residual disease ? patients in remission (Structured abstract)      
Blinatumomab (Blincyto) for relapsed or refractory Philadelphia-positive B-precursor acute lymphoblastic leukaemia ? second or subsequent line (Structured abstract)      
Blinatumomab for relapsed or refractory Philadelphia-negative B-precursor acute lymphoblastic leukaemia (Structured abstract)      
Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial in hibernation, ready for rapid activation (Structured abstract)      
Blood brain barrier disruption chemotherapy (Structured abstract)      
Blood conservation initiatives (Structured abstract)      
Blood count and coagulation testing before renal biopsy (Structured abstract)      
Blood glucose monitors and test strips: a review of the comparative clinical evidence and cost-effectiveness ? an update (Structured abstract)      
Blood glucose monitors and test strips: a review of the comparative clinical evidence and cost-effectiveness (Structured abstract)      
Blood glucose self-monitoring in diabetes management (Structured abstract)      
Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial (Structured abstract)      
Blood glucose test strip use: patterns, costs and potential cost reduction associated with reduced testing (Structured abstract)      
Blood pressure monitoring chairs to identify hypertension: a review of the clinical effectiveness and guidelines (Structured abstract)      
Blood test for early diagnosis of Alzheimer's disease (Structured abstract)      
Blood test for soluble mesothelin-related proteins: used to identify asbestos-exposed individuals who may develop mesothelioma (Structured abstract)      
Blood volume analysis using the BVA-100 blood volume analyzer (Daxor Corp.) for management of patients with chronic heart failure (Structured abstract)      
BLU-U (TM) Blue Light Photodynamic Therapy Illuminator (Structured abstract)      
BluePrint molecular subtyping profile for breast cancer (Structured abstract)      
Bluetooth-enabled hearing technologies: a review of the clinical and cost-effectiveness (Structured abstract)      
BMI reduction and chronic disease management: clinical evidence (Structured abstract)      
BMI reduction and chronic disease management: clinical evidence (Structured abstract)      
BNCT - Radiotherapy with neutrons for brain tumors - early assessment briefs (Alert) (Structured abstract)      
BOA study: prevention of occlusion after bypass surgery - primary research (Structured abstract)      
Board certified intensivists (Structured abstract)      
Boceprevir - Benefit assessment according to §35a Social Code Book V (dossier assessment) (Structured abstract)      
Boceprevir for hepatitis C (Structured abstract)      
Boceprevir for the treatment of genotype 1 chronic hepatitis C (Project record)      
Body stereotactic radiosurgery (Structured abstract)      
BodyTite radiofrequency-assisted liposuction (Structured abstract)      
Bolus versus continuous infusion of antibiotics in paediatric patients and its effect on intravenous access patency (Structured abstract)      
Bolused (vice infused) tranexamic acid in adults experiencing hemorrhagic shock: safety, patient benefits, and guidelines (Structured abstract)      
Bone-anchored cystourethropexy (Structured abstract)      
Bone anchored hearing aid (BAHA): an evidence-based analysis (Structured abstract)      
Bone anchored hearing aid (BAHA(R)) (Structured abstract)      
Bone anchored hearing aid in patients with unilateral hearing loss (Structured abstract)      
Bone-anchored hearing aids (BAHAs) for people who are bilaterally deaf: a systematic review and economic evaluation (Structured abstract)      
Bone-anchored hearing aids (Structured abstract)      
Bone-anchored hearing aids (Structured abstract)      
Bone-anchored implants in the head and neck region (Structured abstract)      
Bone and bone substitute for periodontal rehabilitation and for bone reconstruction before implantation - systematic review of health economics (Structured abstract)      
Bone and bone substitute for periodontal rehabilitation and for bone reconstruction before implantation - systematic review of health economics (Structured abstract)      
Bone and bone substitute for periodontal rehabilitation and for bone reconstruction before implantation - systematic review of medical efficacy (Structured abstract)      
Bone densitometry assessment (Structured abstract)      
Bone densitometry in Catalonia: diffusion and practice (Structured abstract)      
Bone density measurement and treatments of osteoporosis (INAHTA project) (Structured abstract)      
Bone density measurement (Structured abstract)      
Bone density measurement with dedicated CT scanner (Project record)      
Bone graft and substitutes (Structured abstract)      
Bone graft substitutes in traumatology (Structured abstract)      
Bone marrow and peripheral blood stem cell transplantation for malignancy: a review (Structured abstract)      
Bone marrow aspiration or biopsy for patients with immune thrombocytopenia: clinical evidence (Structured abstract)      
Bone marrow transplantation for treatment of multiple sclerosis (Structured abstract)      
Bone marrow transplantation (Structured abstract)      
Bone marrow transplantation using mismatched related and matched unrelated donors: Consideration of eligibility for national funded centre status (Structured abstract)      
Bone mineral density analyses using dual energy x-ray absorptiometry (DXA) for women in their 50th year (Project record)      
Bone mineral density analyses using Dual Energy X-Ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatment (Structured abstract)      
Bone mineral density screening (Structured abstract)      
Bone mineral density testing: does the evidence support its selective use in well women? (Structured abstract)      
Bone mineral testing. Systematic review (Structured abstract)      
Bone morphogenetic protein: the state of the evidence of on-label and off-label use (Structured abstract)      
Bone morphogenetic proteins and bone marrow aspirate concentrate for tibial fractures and long bone nonunions (Structured abstract)      
Bone morphogenetic proteins and spinal surgery for degenerative disc disease: an evidence-based analysis (Structured abstract)      
Bone morphogenetic proteins for use in spinal surgery and long bone trauma surgery: a review of the clinical effectiveness and safety (Structured abstract)      
Bone morphogenic protein for the treatment of long bone fractures and for use in spinal fusion procedures (Structured abstract)      
Bone prosthesis which can be lengthened by a non-invasive electromagnetic procedure (systematic review, expert panel) (Structured abstract)      
Bone substitutes (Structured abstract)      
Boron neutron capture therapy for cancer treatment (Structured abstract)      
Bortezomib for induction therapy in multiple myeloma before high dose chemotherapy and autologous stem cell transplantation (Project record)      
Bortezomib for multiple myeloma - horizon scanning review (Structured abstract)      
Bortezomib for relapsed and/or refractory follicular non-Hodgkins lymphoma (Structured abstract)      
Bortezomib for the treatment of multiple myeloma patients (Structured abstract)      
Bortezomib monotherapy for relapsed multiple myeloma (Structured abstract)      
Bortezomib (Structured abstract)      
Bortezomib (Velcade) for multiple myeloma - first line: horizon scanning technology briefing (Project record)      
Bortezomib (Velcade) for multiple myeloma within a transplant setting (Structured abstract)      
Bortezomib (Velcade) for newly diagnosed mantle cell lymphoma ? first line (Structured abstract)      
Bortezomib (Velcade) for relapsed and refractory multiple myeloma - horizon scanning review (Structured abstract)      
Bortezomib (Velcade) in combination with dexamethasone or pegylated liposomal doxorubicin for relapsed multiple myeloma (Structured abstract)      
Bortezomib (Velcade®) 3.5 mg subcutaneous injection (Structured abstract)      
Bortezomib (Velcade®) as consolidation or maintenance therapy after autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma (Structured abstract)      
Bortezomib (Velcade®) (Structured abstract)      
Bortezomib (Velcade®) (Structured abstract)      
Bosentan (Structured abstract)      
Bosentan (Tracleer) (Structured abstract)      
Boston Equalens scleral contact lens (Polymer Technology Corp.) for severe ocular surface disease (Structured abstract)      
Bosutinib: assessment according to § 35a (para. 1, sentence 10) Social Code Book V (dossier assessment) (Structured abstract)      
Bosutinib for chronic myeloid leukaemia - first/second line (Structured abstract)      
Bosutinib for previously treated chronic myeloid leukaemia (Project record)      
Botulinum toxin A (Dysport) for hyperhidrosis of the axillae (Structured abstract)      
Botulinum toxin A for headaches in adults: a review of clinical-effectiveness and safety (Structured abstract)      
Botulinum toxin A for myofascial pain syndrome: a review of the clinical effectiveness (Structured abstract)      
Botulinum toxin A for the management of pelvic pain and urinary incontinence in women: a review of the clinical-effectiveness and safety (Structured abstract)      
Botulinum toxin A for the treatment of refractory chronic anal fissures and internal anal sphincter achalasia in pediatric patients (Structured abstract)      
Botulinum toxin A for the treatment of trigeminal neuralgia and temporomandibular joint dysfunction: a review of the clinical-effectiveness (Structured abstract)      
Botulinum toxin A for upper and lower limb spasticity: a systematic review (Structured abstract)      
Botulinum toxin A in the treatment of morbid obesity (Structured abstract)      
Botulinum toxin A in the treatment of upper and lower limb spasticity: a systematic review of randomized controlled trials (Structured abstract)      
Botulinum toxin for the treatment of headache (Structured abstract)      
Botulinum toxin for treatment of hyperhidrosis (Structured abstract)      
Botulinum toxin for treatment of primary chronic headache disorders (Structured abstract)      
Botulinum toxin for treatment of primary chronic headache disorders (Structured abstract)      
Botulinum toxin in obstetric paralysis (Structured abstract)      
Botulinum toxin: indications, costs, and situation in other communities in Spain (Structured abstract)      
Botulinum toxin treatment for chronic anal fissure (Structured abstract)      
Botulinum toxin treatment for chronic tension-type headache (Structured abstract)      
Botulinum toxin treatment for detrusor instability (Structured abstract)      
Botulinum toxin treatment for dystonias (Structured abstract)      
Botulinum toxin treatment for esophageal achalasia (Structured abstract)      
Botulinum toxin treatment for essential tremor and spasticity for indications other than cerebral palsy and stroke (Structured abstract)      
Botulinum toxin treatment for gastroparesis (Structured abstract)      
Botulinum toxin treatment for hyperhidrosis (Structured abstract)      
Botulinum toxin treatment for migraine headache (Structured abstract)      
Botulinum toxin treatment for primary headache (Structured abstract)      
Botulinum toxin treatment for spasticity due to cerebral palsy (Structured abstract)      
Botulinum toxin treatment for spasticity following stroke (Structured abstract)      
Botulinum toxin treatment of axillary and palmar hyperhidrosis (Structured abstract)      
Botulinum toxin type A (Botox) for chronic migraine (Structured abstract)      
Botulinum toxin type A (Botox®) (Structured abstract)      
Botulinum toxin type A for prophylactic treatment of chronic migraine (Structured abstract)      
Botulinum toxin type A for the prophylaxis of headaches in adults with chronic migraine (Project record)      
Botulinum toxin type A injection for achalasia and anal fissure (Structured abstract)      
Botulinum toxin type A injection into the ilopsoas muscle (Structured abstract)      
Botulinum toxin use in adults and children with urinary tract function disorders (Structured abstract)      
BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A (Structured abstract)      
BpTRU (TM) blood pressure monitor for use in a physician's office (Structured abstract)      
BRACAnalysis genetic test (Structured abstract)      
Brachytherapy and prostate cancer (Structured abstract)      
Brachytherapy for accelerated partial breast irradiation after breast-conserving surgery for early stage breast cancer (Structured abstract)      
Brachytherapy for breast cancer (Structured abstract)      
Brachytherapy for breast cancer (Structured abstract)      
Brachytherapy for localised prostate cancer (Structured abstract)      
Brachytherapy for malignant gliomas (Structured abstract)      
Brachytherapy for prostate cancer (Structured abstract)      
Brachytherapy for prostate cancer (Structured abstract)      
Brachytherapy for prostate cancer (Structured abstract)      
Brachytherapy for prostate cancer treatment (Structured abstract)      
Brachytherapy for prostatic cancer - early assessment briefs (ALERT) (Structured abstract)      
Brachytherapy for the prevention of restenosis in peripheral arteries following PTA of the femoropopliteal system (Structured abstract)      
Brachytherapy for the treatment of prostate cancer: assessment report May 2005 (Structured abstract)      
Brachytherapy for the treatment of prostate cancer (Structured abstract)      
Brachytherapy for the treatment of prostate cancer (Structured abstract)      
Brachytherapy for the treatment of prostate cancer (Structured abstract)      
Brachytherapy for treatment of prostate cancer (Structured abstract)      
Brachytherapy in early localized prostate cancer (Structured abstract)      
Brachytherapy in the treatment of gynaecological and other cancers. IPE-00/24 (Public report) (Structured abstract)      
Brachytherapy/proton beam therapy for clinically localized, low-risk prostate cancer (Structured abstract)      
Bracing after knee arthroscopy: a rapid review (Structured abstract)      
BRAF gene mutation analysis (Structured abstract)      
BRAF Gene, Mutation(Peptide Nucleic Acid Mediated Real-time PCR Clamping Method) (Structured abstract)      
BRAF p.Val600Glu testing in papillary thyroid carcinoma (Structured abstract)      
BRAF p.Val600Glu (V600E) and p.Val600Lys (V600K) testing for trametinib monotherapy in melanoma (Structured abstract)      
BRAF p.Val600Glu (V600E) testing for assessment of treatment options in metastatic colorectal cancer (Structured abstract)      
BRAF p.Val600Glu (V600E) testing to predict response to vemurafenib in malignant melanoma (Structured abstract)      
BRAF V600E mutation (Structured abstract)      
Brahms PCT Assays for the diagnosis and control treatment of systemic bacterial infection in emergency and intensive care patients (Structured abstract)      
Brahms PCT assays for the diagnosis of systemic bacterial infection (Structured abstract)      
Brain damage in boxers and soccer players. Review. Expert panel (Structured abstract)      
Brain death criteria (Organ donation Act) (Structured abstract)      
Brain death criteria (Structured abstract)      
Brain death protocol (Structured abstract)      
Brain disorders in Ontario: prevalence, incidence and costs from health administrative data (Structured abstract)      
Brain electrical activity mapping for diagnosing psychiatric disorders: a review of the clinical evidence (Structured abstract)      
[Brain injury rehabilitation - a Health Technology Assessment] (Structured abstract)      
Brain natriuretic peptide testing for congestive heart failure: a review of the guidelines and clinical and cost-effectiveness (Structured abstract)      
Brainstem Auditory Evoked Response (BAER) for assessment of brainstem dysfunction in patients with chiari malformations (Structured abstract)      
BRATS 01: Entecavir for the treatment of chronic hepatitis-B (Structured abstract)      
BRATS 02: Drotecogin alfa for the treatment of serious sepsis (Structured abstract)      
BRATS 03: Nucleic acids amplification tests (NAT) and other strategies for the detection of HIV-1 and HCV viruses in the selection of donated blood (Structured abstract)      
BRATS 04: Multiple-detector computed tomography for the diagnosis of coronary artery disease (Structured abstract)      
BRATS 05: Bariatric surgery for the treatment of morbid obesity (Structured abstract)      
BRATS 06: Angiogenesis inhibitors for the treatment of age-related macular degeneration (Structured abstract)      
BRATS 07: Deferasirox for the treatment of iron overload (Structured abstract)      
BRATS 08: Drug-eluting stents and bare-metal stents in the treatment of coronary artery disease (Structured abstract)      
BRATS 09: Statins for the prevention of cardiovascular events (Structured abstract)      
BRATS 10: Rituximab in the treatment of diffuse large B-cell non-Hodgkin's lymphoma (DLBCL) (Structured abstract)      
BRATS 11: Positron Emission Tomography (PET) in the diagnosis, staging and restaging of patients with colorectal cancer (Structured abstract)      
BRATS 12: Clinical strategies for smoking cessation (Structured abstract)      
BRATS 13: The use of insulin glargine and insulin detemir to control type 1 diabetes mellitus (Structured abstract)      
Bravo pH monitoring in gastroesophageal reflux (Structured abstract)      
BRCA1 and BRCA2 predictive genetic testing for breast and ovarian cancers: a systematic review of clinical evidence (Structured abstract)      
BRCA1 and BRCA2 sequence variant analysis for susceptibility to hereditary ovarian cancer (Structured abstract)      
Breast and gynaecological cancer screening in Hungary: Cost effectiveness analysis, (in: Dorossy L, Organised screening in oncology; Guidebook in quality improvement and methodology) (Structured abstract)      
Breast cancer ablation with radiofrequency. Systematic review (Structured abstract)      
Breast cancer diagnosis using ultrasound elasticity imaging (Structured abstract)      
Breast cancer diagnosis using ultrasound elasticity imaging (Structured abstract)      
Breast cancer in women: diagnosis, treatment and follow-up (Structured abstract)      
Breast Cancer Index (BCI) (Structured abstract)      
Breast cancer screening and medication (Project record)      
Breast cancer screening in Catalonia: cost-effectiveness, health care impact and cost of the treatment of breast cancer (Structured abstract)      
Breast cancer screening through mammography. IPE-95/05 (Public report) (Structured abstract)      
Breast cancer (Structured abstract)      
Breast cancer susceptibility 1 and 2 (BRCA1/2) gene testing for hereditary breast and ovarian cancer (HBOC) (Structured abstract)      
Breast cancer susceptibility 1 and 2 (BRCA1/2) gene testing for hereditary breast and ovarian cancer (HBOC) (Structured abstract)      
Breast cancer susceptibility 1 and 2 (BRCA1/2) sequence variant testing for susceptibility to hereditary breast cancer (Structured abstract)      
Breast ductal lavage and fiberoptic ductoscopy for breast cancer diagnosis and screening (Structured abstract)      
Breast magnetic resonance imaging (MRI) (1098) (Project record)      
Breast magnetic resonance imaging (MRI) (Structured abstract)      
Breast magnetic resonance imaging (MRI) (Structured abstract)      
Breast MRI for detection or diagnosis of primary or recurrent breast cancer (Structured abstract)      
Breast MRI for management of patients with locally advanced breast cancer who are being referred for neoadjuvant chemotherapy (Structured abstract)      
Breast OncoGuide (Structured abstract)      
Breast prosthesis implantation for reconstructive and cosmetic surgery: a rapid review (Structured abstract)      
Breast reduction surgery for hypermastia: clinical effectiveness and guidelines (Structured abstract)      
Breast-Specific Gamma Imaging (BSGI), Molecular Breast Imaging (MBI), or scintimammography with breast-specific gamma camera (Structured abstract)      
Breast-specific gamma imaging (BSGI) (Structured abstract)      
Breast-specific gamma imaging (BSGI) using the dilon 6800 gamma camera (Dilon Technologies Inc.) (Structured abstract)      
Breast-Specific Gamma Imaging (BSGI) using the Dilon 6800 gamma camera (Dilon Technologies Inc.) (Structured abstract)      
Breast tomosynthesis: a breast cancer screening tool (Structured abstract)      
Breast Tomosynthesis: a breast cancer screening tool (Structured abstract)      
BreastCare (TM)/BreastAlert (TM) (Structured abstract)      
Breastfeeding and maternal and infant health outcomes in developed countries (Structured abstract)      
Breastfeeding promotion for infants in neonatal units: a systematic review and economic analysis (Structured abstract)      
Breath test for detection of insulin resistance (Diatest TM) (Structured abstract)      
Breath test for lung cancer detection in high-risk patients (Structured abstract)      
Breath test for lung cancer screening - horizon scanning review (Structured abstract)      
Breath test for the detection of impaired glucose tolerance (Structured abstract)      
Breath test for the detection of lung cancer in high-risk patients (Structured abstract)      
BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group Phase II/III trial (Structured abstract)      
Breathing exercises and/or retraining techniques in the treatment of asthma: comparative effectiveness (Structured abstract)      
BreathLink? for breast cancer screening (Structured abstract)      
Brentuximab (Adcetris®) for the treatment of relapsed Hodgkin's lymphoma (HL) or relapsed systemic anaplastic large cell lymphoma (sALCL) (Structured abstract)      
Brentuximab for refractory CD30+ hodgkin's lymphoma: clinical and cost-effectiveness (Structured abstract)      
Brentuximab vedotin (Adcetris) for CD30-positive cutaneous T-cell lymphoma (Structured abstract)      
Brentuximab vedotin (Adcetris) for hodgkin lymphoma (Structured abstract)      
Brentuximab vedotin (Adcetris®) (Structured abstract)      
Brentuximab Vedotin - Assessment according to § 35a (para. 1, sentence 10) Social Code Book V (dossier assessment) (Structured abstract)      
Brentuximab vedotin for Hodgkin´s lymphoma (Structured abstract)      
Brentuximab vedotin for hodgkin's lymphoma, relapsing or remitting - first line (Structured abstract)      
Brentuximab vedotin for relapsed or refractory Hodgkin's lymphoma (Structured abstract)      
Brentuximab vedotin for systemic anaplastic large cell lymphoma relapsed and/or refractory - first line (Structured abstract)      
Brentuximab vedotin in lymphomas (Structured abstract)      New 
Bridging the gap: the use of research evidence in policy development (Structured abstract)      
Brief interventions and alcohol use (Structured abstract)      
Brief interventions and referral for smoking cessation in primary care and other settings (Structured abstract)      
Brief report - Collection devices for cervical screening (Structured abstract)      
Brief screening tests for depression in emergency patients (Structured abstract)      
Brimonidine (Mirvaso®) (Structured abstract)      
Bristol Girls Dance Project: a cluster randomised controlled trial of an after-school dance programme to increase physical activity among 11- to 12-year-old girls (Structured abstract)      
The British Antibiotic and Silver Impregnated Catheters for ventriculoperitoneal Shunts multi-centre randomised controlled trial (The BASICS trial) (Project record)      
The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis (Structured abstract)      
Brivanib alaninate for hepatocellular cancer (Structured abstract)      
Brivanib for hepatocellular carcinoma ? second line (Structured abstract)      
Brivaracetam - benefit assessment according to §35a Social Code Book V (Structured abstract)      
Broadband services for disabled persons - assessment of user benefits (Structured abstract)      
Brodalumab for moderate to severe plaque psoriasis (Structured abstract)      
Bromocriptine, quick release (Syncroset) for type 2 diabetes mellitus (Structured abstract)      
Bronchial provocation test (Structured abstract)      
Bronchial thermoplasty for severe asthma: clinical and cost-effectiveness, and guidelines (Structured abstract)      
Bronchial thermoplasty for the treatment of severe persistent asthma (Structured abstract)      
Bronchial thermoplasty for treatment of asthma (Structured abstract)      
Bronchial thermoplasty for treatment of asthma (Structured abstract)      New 
Bronchial thermoplasty for treatment of inadequately controlled severe asthma (Structured abstract)      
Bronchial thermoplasty (Structured abstract)      
Bronchiolitis of Infancy Discharge Study (BIDS): a multicentre, parallel-group, double-blind, randomised controlled, equivalence trial with economic evaluation (Structured abstract)      
Brugada syndrome (Structured abstract)      
Bryan cervical disc system (Medtronic Sofamor Danek) for degenerative disc disease (Structured abstract)      
BST-CarGel (TM) for cartilage repair (Structured abstract)      
Buccal insulin (Oral-Lyn) for diabetes types 1 and 2: horizon scanning technology briefing (Project record)      
Bucelipase-alfa (Kiobrina) for pre-term infants (Structured abstract)      
BuddyWOTCH? to monitor COPD (Structured abstract)      
Budget impact analysis of increasing kidney transplantation in Québec (Structured abstract)      
Building planning and infection control: hand hygiene dispensers and individual bathrooms in residential and long-term care centres (Structured abstract)      
Buparlisib in combination with fulvestrant for hormone-receptor positive/HER2-negative locally advanced or metastatic breast cancer (Structured abstract)      
Buparlisib with fulvestrant for postmenopausal women with metastatic oestrogen-receptor positive, HER2 negative breast cancer ? third line (Structured abstract)      
Bupivacaine hydrochloride (1 mg/ml or 1.25 mg/ml) and fentanyl (2 micrograms/ml) solution for infusion (Bufyl®) (Structured abstract)      
Buprenorphine/naloxone (Suboxone) film versus buprenorphine/naloxone tablets for the treatment of opioid addiction: comparative safety (Structured abstract)      
Buprenorphine/naloxone (Suboxone®) as substitution treatment for opioid dependence (Structured abstract)      
Bupropion for adults with attention deficit hyperactivity disorder: a review of the clinical effectiveness and harms of misuse (Structured abstract)      
Bupropion for smoking cessation (Structured abstract)      
Bupropion, mirtazapine, and reboxetine in the treatment of depression (Structured abstract)      
Bupropion (Zyban) in smoking cessation - early assessment briefs (Alert) (Structured abstract)      
Burden of irritable bowel syndrome in Korea (Structured abstract)      
Buteyko breathing technique for treatment of asthma (Structured abstract)      
BY-BAND. Gastric Bypass or adjustable gastric Banding surgery to treat morbid obesity: a multi-centre randomised controlled trial (Project record)      
Bypass materials in vascular surgery (Structured abstract)      
Bypass operation of the beating heart in comparison to the operation with support of the heart-lung machine (Structured abstract)      
Bypass prostheses (Structured abstract)      
Bypass surgery performed with or without the use of heart-lung machine (Structured abstract)